Where science meets innovation.
Our approach is grounded in scientific rigor, patient-centered care, and evolving research. We integrate therapies informed by peer-reviewed studies and ongoing advancements in regenerative biology, ensuring that our protocols remain aligned with emerging discoveries. As the field of restorative medicine progresses, Decima remains committed to evaluating and integrating next-generation breakthroughs responsibly and ethically.
Inside our Lab+
At Decima, we prioritize the highest standards of quality, safety, and transparency in regenerative medicine. Our biologic materials undergo rigorous assessment, including processing in our partner labs, followed by independent verification through three separate third-party testing facilities. This ensures a thorough evaluation of viability, purity, and safety across all necessary parameters for both stem cells and MUSE cells.
Our laboratory team includes scientists and researchers with backgrounds in some of the best in regenerative medicine programs.
We apply this deep scientific foundation to maintain rigorous, multi-step quality verification, independent third-party testing, and adherence to globally recognized laboratory protocols, including Good Manufacturing Practices (GMP) and ISO-certified standards. Our commitment is to provide the highest level of safety, transparency, and precision in the evolving field of regenerative medicine.
Research+ Data Transparency
Our Commitment is to Open Science>
At Decima, we are committed to scientific transparency and data driven science. Our approach to regenerative medicine is rooted in studied research, independent validation, and real world clinical observations.
Open Access to Data: We share anonymized treatment insights collected through patient-reported outcomes and laboratory assessments. Our goal is to provide transparency in how regenerative therapies are being studied and evaluated.
Commitment to Research: Our protocols are informed by peer reviewed studies, global clinical advancements, and collaborations with experts in the field of restorative medicine.
Scientific Partnerships: We engage with researchers and institutions conducting studies on regenerative biologics, contributing to the ongoing exploration of stem cell applications and immune modulation.At Decima Stem Cells, patient safety, regulatory compliance, and medical excellence are at the core of our operations. We adhere to the highest standards of ethical, medical, and scientific integrity, ensuring that all stem cell treatments follow rigorous protocols and are delivered with transparency and precision.
Stem Cell Sourcing & Treatment Options
We provide two options for stem cell therapy, allowing patients to choose the best fit for their needs:
USA-Based Stem Cells – Sourced from FDA-compliant laboratories, following the highest regulatory standards.
International Stem Cells – An advanced option used by top athletes and leading functional medicine doctors for their patients. These stem cells comply with COFEPRIS (Mexico’s Health Regulatory Authority) and undergo rigorous safety testing. This is where we source our MUSE cells, an advanced type of stem cell known for its regenerative potential.
Regardless of location, all treatments use our stem cells, developed under strict quality control and handled exclusively by our network of trusted providers.
Regulatory Adherence & Certifications
FDA-Compliant Labs (USA Option) – Our U.S.-based stem cells are processed in FDA-registered, compliant laboratories to meet national regulatory requirements.
COFEPRIS Compliance (Mexico Option) – All treatments performed in Mexico adhere to COFEPRIS (Federal Commission for Protection against Health Risks) regulations for biological therapies.
Good Manufacturing Practice (GMP) Standards – All stem cells undergo strict GMP protocols to ensure sterility, potency, and safety.
ISO 9001 & ISO 13485 Certifications – Our stem cell processing facilities meet internationally recognized ISO standards for medical-grade biologics.
Independent Third-Party Testing – Every batch undergoes comprehensive quality control, including viability, purity, and sterility testing by accredited laboratories.
Ethical Sourcing & Compliance – All stem cells are ethically sourced from rigorously screened, healthy donors, with full donor consent and adherence to international medical ethics guidelines.
Stem cell treatments offered by Decima Stem Cells are performed in compliance with both FDA-compliant U.S. labs and COFEPRIS-regulated international standards in Mexico. While some of our therapies are not yet FDA-approved in the United States, they adhere to rigorous medical and ethical guidelines. We encourage all patients to conduct thorough research and consult with their primary healthcare provider before pursuing treatment.
What Informs our protocols
-
![]()
Wharton’s Jelly Stem Cells Improve Heart Function Post-Attack
A 5-year study shows Wharton’s Jelly stem cells boost heart function in heart attack patients, with benefits peaking at 1 year and lasting long-term.
-
![]()
Safety of Muse Cells for Spinal Cord Injury: Clinical Trial Results
A human trial demonstrated that intravenous Muse cells are safe and well-tolerated in patients with cervical spinal cord injuries, with no adverse events and potential improvements in motor function.
-
![]()
Muse Cells: Safe, Pluripotent Stem Cells for Regenerative Healing
Muse cells are a unique type of pluripotent stem cell that naturally occur in human tissues. They are stress-resistant, non-tumorigenic, and can regenerate damaged tissues like cartilage, heart, and brain cells. These qualities position Muse cells as a promising, safe option for regenerative therapies.
-
![]()
Wharton’s Jelly Stem Cells: The Superior Choice for Osteoarthritis Repair
This review highlights Wharton's jelly-derived stem cells (WJ-MSCs) as superior for osteoarthritis therapy due to their high chondrogenic potential, anti-inflammatory properties, and low immunogenicity. Compared to other stem cells, WJ-MSCs show enhanced cartilage repair capabilities, making them a promising option for treating osteoarthritis.
-
![]()
Clinical Effects of Intrathecal Wharton's Jelly MSCs in Chronic Spinal Cord Injury: A Randomized Study
Investigates the safety and potential therapeutic benefits of administering Wharton's jelly-derived mesenchymal stromal cells (WJ-MSCs) directly into the spinal canal of patients suffering from chronic complete spinal cord injuries. The research aims to assess whether this treatment can improve neurological function and quality of life in affected individuals.
